Literature DB >> 8891611

Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands.

F Meng1, Y Ueda, M T Hoversten, R C Thompson, L Taylor, S J Watson, H Akil.   

Abstract

While a good deal has been learned about determinants of high affinity ligand/receptor interactions in G-protein-coupled receptors, less is known about mechanisms of ligand selectivity. The opioid receptors offer an excellent opportunity to study the mechanisms whereby structurally very similar receptors discriminate between different but structurally highly related ligands. In the current study, we use a series of chimeric constructs between the delta-opioid receptor and either the mu- or the kappa-opioid receptors to investigate the structural basis of binding selectivity of multiple classes of delta-opioid receptor selective ligands. Our results demonstrate that a region containing the sixth transmembrane domain (TM6) and the third extracellular loop (EL3) in the delta-opioid receptor is absolutely critical for delta-opioid receptor selectivity. The introduction of this region into the kappa-opioid receptor is sufficient to impart a delta profile for delta-opioid receptor selective alkaloids such as naltrindole and naltriben. In order to locate the amino acid residues that may be involved in ligand selectivity in TM6 and EL3 of the delta-opioid receptor, several mutations were introduced into that region. These mutations showed differential effects on peptide and alkaloid ligands. In addition, none of the individual mutations alone could account for the changes exhibited by the chimeric receptors. We conclude that the selectivity of most delta-opioid ligands is achieved through their interaction with many different residues in the TM6/EL3 region. Our results also support a view that the extracellular domains of peptide receptors may provide the basis of a sorting mechanism for ligand selectivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891611     DOI: 10.1016/0014-2999(96)00431-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Molecular recognition of opioid receptor ligands.

Authors:  Brian E Kane; Bengt Svensson; David M Ferguson
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

2.  Docking studies suggest ligand-specific delta-opioid receptor conformations.

Authors:  Vuk Micovic; Milovan D Ivanovic; Ljiljana Dosen-Micovic
Journal:  J Mol Model       Date:  2008-12-04       Impact factor: 1.810

3.  Controlling signaling with a specifically designed Gi-coupled receptor.

Authors:  P Coward; H G Wada; M S Falk; S D Chan; F Meng; H Akil; B R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.

Authors:  S Allouche; J Polastron; A Hasbi; V Homburger; P Jauzac
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

Review 5.  Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons.

Authors:  Xu Zhang; Lan Bao
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

6.  Modeling and simulation of the human delta opioid receptor.

Authors:  Mahalaxmi Aburi; Paul E Smith
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

7.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

Authors:  I D Pogozheva; A L Lomize; H I Mosberg
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

8.  A new cytokine: the possible effect pathway of methionine enkephalin.

Authors:  Xin-Hua Liu; Dong-Ai Huang; Fei-Yi Yang; Yan-Sheng Hao; Guo-Guang Du; Ping-Feng Li; Gang Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

9.  Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists.

Authors:  Tobias Claff; Jing Yu; Véronique Blais; Nilkanth Patel; Charlotte Martin; Lijie Wu; Gye Won Han; Brian J Holleran; Olivier Van der Poorten; Kate L White; Michael A Hanson; Philippe Sarret; Louis Gendron; Vadim Cherezov; Vsevolod Katritch; Steven Ballet; Zhi-Jie Liu; Christa E Müller; Raymond C Stevens
Journal:  Sci Adv       Date:  2019-11-27       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.